On December 7th, 2020, America Great Health, a California Corporation (“AAGH California”), a wholly owned subsidiary of America Great Health (the “Company”), entered into a Cooperation Agreement (the “Agreement”) with Brilliant Healthcare Limited. (“Brilliant”) pursuant to which the parties will establish a joint venture in China (the “JV Company”) for the purpose of promoting and developing stem cell related product’s R&D, production, sales, row material procumbent, mergers and acquisitions, and consulting services. The Company shall invest USD $4.2 million in the JV Company within the next 24 months for 60% equity ownership of the JV Company, Brilliant shall transfer its patented technology (with estimated value of USD $29.8 million) to the JV Company as its capital contribution, to account for 40% equity ownership. |
America Great Health entered into a Cooperation Agreement with Brilliant Healthcare Limited to establish a joint venture in China for promoting and developing stem cell related products
Earlier from America Great Health
- America Great Health(OTC: AAGH) entered into an Asset Purchase Agreement with Chaoyang Tianma
- America Great Health California established a JV with Guangzhou Bona Biotechnology Co., Ltd. for health and cosmetics related products supplied by AAGH California in China
- Corporate changed name and stock symbol from Crown Marketing (CWNM) to America Great Health (AAGH)
- Crown Laboratory, a Subsidiary of Crown Marketing announces a LOI with XinJiang Top Agricultural Public Limited Company in China to Export Alfalfa from California to China
